General adverse reaction to aspirin administered by transdermal iontophoresis.
Macchia
Luigi
L
Caiaffa
Maria F
MF
Vacca
Adele
A
Tursi
Alfredo
A
D000279:Administration, Cutaneous; D000293:Adolescent; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects*; D000799:Angioedema / Q000139:chemically induced; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D003371:Cough / Q000139:chemically induced; D004417:Dyspnea / Q000139:chemically induced; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D007478:Iontophoresis; D008239:Lysine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D008297:Male; D015508:Nasal Obstruction / Q000139:chemically induced; D011537:Pruritus / Q000139:chemically induced
D000700:Analgesics; D008239:Lysine; D001241:Aspirin; C010395:acetylsalicylic acid lysinate